BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 32909650)

  • 1. Four-Year Follow-up of [
    Kogan RV; Janzen A; Meles SK; Sittig E; Renken RJ; Gurvits V; Mayer G; Leenders KL; Oertel WH;
    Mov Disord; 2021 Jan; 36(1):230-235. PubMed ID: 32909650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid Eye Movement Sleep Behavior Disorder: Abnormal Cardiac Image and Progressive Abnormal Metabolic Brain Pattern.
    Janzen A; Kogan RV; Meles SK; Sittig E; Renken RJ; Geibl FF; Booij J; Stormezand G; Luster M; Mayer G; Leenders KL; Oertel WH
    Mov Disord; 2022 Mar; 37(3):624-629. PubMed ID: 34796976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder.
    Meles SK; Vadasz D; Renken RJ; Sittig-Wiegand E; Mayer G; Depboylu C; Reetz K; Overeem S; Pijpers A; Reesink FE; van Laar T; Heinen L; Teune LK; Höffken H; Luster M; Kesper K; Adriaanse SM; Booij J; Leenders KL; Oertel WH
    Mov Disord; 2017 Oct; 32(10):1482-1486. PubMed ID: 28734065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivation and Validation of a Phenoconversion-Related Pattern in Idiopathic Rapid Eye Movement Behavior Disorder.
    Mattioli P; Orso B; Liguori C; Famà F; Giorgetti L; Donniaquio A; Massa F; Giberti A; Vállez García D; Meles SK; Leenders KL; Placidi F; Spanetta M; Chiaravalloti A; Camedda R; Schillaci O; Izzi F; Mercuri NB; Pardini M; Bauckneht M; Morbelli S; Nobili F; Arnaldi D
    Mov Disord; 2023 Jan; 38(1):57-67. PubMed ID: 36190111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the MDS research criteria for prodromal Parkinson's disease: Longitudinal assessment in a REM sleep behavior disorder (RBD) cohort.
    Fereshtehnejad SM; Montplaisir JY; Pelletier A; Gagnon JF; Berg D; Postuma RB
    Mov Disord; 2017 Jun; 32(6):865-873. PubMed ID: 28429825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of clinical markers in prodromal Parkinson's disease and dementia with Lewy bodies: a multicentre study.
    Joza S; Hu MT; Jung KY; Kunz D; Stefani A; Dušek P; Terzaghi M; Arnaldi D; Videnovic A; Schiess MC; Hermann W; Lee JY; Ferini-Strambi L; Lewis SJG; Leclair-Visonneau L; Oertel WH; Antelmi E; Sixel-Döring F; Cochen De Cock V; Liguori C; Liu J; Provini F; Puligheddu M; Nicoletti A; Bassetti CLA; Bušková J; Dauvilliers Y; Ferri R; Montplaisir JY; Lawton M; Kim HJ; Bes F; Högl B; Šonka K; Fiamingo G; Mattioli P; Lavadia ML; Suescun J; Woo KA; Marelli S; Martens KE; Janzen A; Plazzi G; Mollenhauer B; Fernandes M; Li Y; Cortelli P; Figorilli M; Cicero CE; Schaefer C; Guiraud L; Lanza G; Gagnon JF; Sunwoo JS; Ibrahim A; Girtler N; Trenkwalder C; Baldelli L; Pelletier A; Postuma RB;
    Brain; 2023 Aug; 146(8):3258-3272. PubMed ID: 36881989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Metabolic Pattern of Idiopathic REM Sleep Behavior Disorder Reflects Early-Stage Parkinson Disease.
    Meles SK; Renken RJ; Janzen A; Vadasz D; Pagani M; Arnaldi D; Morbelli S; Nobili F; Mayer G; Leenders KL; Oertel WH;
    J Nucl Med; 2018 Sep; 59(9):1437-1444. PubMed ID: 29476004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease.
    Meles SK; Oertel WH; Leenders KL
    Mol Med; 2021 Sep; 27(1):111. PubMed ID: 34530732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson Disease-Related Brain Metabolic Patterns and Neurodegeneration in Isolated REM Sleep Behavior Disorder.
    Shin JH; Lee JY; Kim YK; Yoon EJ; Kim H; Nam H; Jeon B
    Neurology; 2021 Jul; 97(4):e378-e388. PubMed ID: 34011571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occipital hypometabolism is a risk factor for conversion to Parkinson's disease in isolated REM sleep behaviour disorder.
    Carli G; Meles SK; Janzen A; Sittig E; Kogan RV; Perani D; Oertel WH; Leenders KL;
    Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3290-3301. PubMed ID: 37310428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal Changes in Isolated Rapid Eye Movement Sleep Behavior Disorder-Related Metabolic Pattern Expression.
    Kim R; Lee JY; Kim YK; Kim H; Yoon EJ; Shin JH; Yoo D; Nam H; Jeon B
    Mov Disord; 2021 Aug; 36(8):1889-1898. PubMed ID: 33788284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of prodromal Parkinson's disease and dementia with Lewy bodies: a prospective study.
    Fereshtehnejad SM; Yao C; Pelletier A; Montplaisir JY; Gagnon JF; Postuma RB
    Brain; 2019 Jul; 142(7):2051-2067. PubMed ID: 31111143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing the heterogeneous metabolic progression in idiopathic REM sleep behavior disorder.
    Han X; Wu P; Alberts I; Zhou H; Yu H; Bargiotas P; Yakushev I; Wang J; Höglinger G; Förster S; Bassetti C; Oertel W; Schwaiger M; Huang SC; Cumming P; Rominger A; Jiang J; Zuo C; Shi K
    Neuroimage Clin; 2020; 27():102294. PubMed ID: 32570206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive Olfactory Impairment and Cardiac Sympathetic Denervation in REM Sleep Behavior Disorder.
    Janzen A; Vadasz D; Booij J; Luster M; Librizzi D; Henrich MT; Timmermann L; Habibi M; Sittig E; Mayer G; Geibl F; Oertel W
    J Parkinsons Dis; 2022; 12(6):1921-1935. PubMed ID: 35754288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accurate Detection of α-Synuclein Seeds in Cerebrospinal Fluid from Isolated Rapid Eye Movement Sleep Behavior Disorder and Patients with Parkinson's Disease in the DeNovo Parkinson (DeNoPa) Cohort.
    Concha-Marambio L; Weber S; Farris CM; Dakna M; Lang E; Wicke T; Ma Y; Starke M; Ebentheuer J; Sixel-Döring F; Muntean ML; Schade S; Trenkwalder C; Soto C; Mollenhauer B
    Mov Disord; 2023 Apr; 38(4):567-578. PubMed ID: 36781413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. REM Sleep Behavior Disorder in Parkinson's Disease and Other Synucleinopathies.
    St Louis EK; Boeve AR; Boeve BF
    Mov Disord; 2017 May; 32(5):645-658. PubMed ID: 28513079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Transferrin Sialylation Predicts Phenoconversion in Isolated REM Sleep Behavior Disorder.
    Ganapathy S R; Levová K; Kotačková L; Trnka J; Zogala D; Rusz J; Zima T; Devos D; Šonka K; Růžička E; Kalousová M; Dušek P
    Mov Disord; 2022 May; 37(5):983-992. PubMed ID: 35128728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced Gastric Contraction in Rapid-Eye-Movement Sleep Behavior Disorder and De Novo Parkinson's Disease.
    Oertel WH; Paule E; Hasemann T; Sittig E; Belke M; Unger MM; Mayer G; Werner R; Jansen A; Pape H; Höglinger GU; Vadasz D; Müller HH; Knake S; Janzen A
    Mov Disord; 2024 Jan; 39(1):53-63. PubMed ID: 37955157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tract-Based Spatial Statistics Reveal Lower White Matter Integrity Specific to Idiopathic Rapid Eye Movement Sleep Behavior Disorder as a Proxy for Prodromal Parkinson's Disease.
    Ohlhauser L; Smart CM; Gawryluk JR
    J Parkinsons Dis; 2019; 9(4):723-731. PubMed ID: 31498130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDG-PET combined with learning vector quantization allows classification of neurodegenerative diseases and reveals the trajectory of idiopathic REM sleep behavior disorder.
    van Veen R; Meles SK; Renken RJ; Reesink FE; Oertel WH; Janzen A; de Vries GJ; Leenders KL; Biehl M
    Comput Methods Programs Biomed; 2022 Oct; 225():107042. PubMed ID: 35970056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.